Zobrazeno 1 - 10
of 281
pro vyhledávání: '"G. S. BISACCHI"'
Autor:
Cabua MC; CNRS, ICMMO, CP3A Organic Synthesis Group, Université Paris-Saclay, 17 Avenue des Sciences, 91400, Orsay, France.; Department of Chemical and Geological Science, University of Cagliari, S.P. No. 8 Km 0.700, 09042, Monserrato, Italy., He X; CNRS, ICMMO, CP3A Organic Synthesis Group, Université Paris-Saclay, 17 Avenue des Sciences, 91400, Orsay, France., Secci F; Department of Chemical and Geological Science, University of Cagliari, S.P. No. 8 Km 0.700, 09042, Monserrato, Italy., Deloisy S; CNRS, ICMMO, CP3A Organic Synthesis Group, Université Paris-Saclay, 17 Avenue des Sciences, 91400, Orsay, France., Aitken DJ; CNRS, ICMMO, CP3A Organic Synthesis Group, Université Paris-Saclay, 17 Avenue des Sciences, 91400, Orsay, France.
Publikováno v:
ChemistryOpen [ChemistryOpen] 2024 Oct 30, pp. e202400279. Date of Electronic Publication: 2024 Oct 30.
Autor:
J C, Barrish, E, Gordon, M, Alam, P F, Lin, G S, Bisacchi, P, Chen, P T, Cheng, A W, Fritz, J A, Greytok, M A, Hermsmeier
Publikováno v:
Journal of Medicinal Chemistry. 37:1758-1768
A series of HIV protease inhibitors containing a novel C2 symmetrical "aminodiol" core structure were prepared from amino acid starting materials. The ability of the aminodiols to inhibit HIV replication in cell culture is comparable to their ability
Publikováno v:
Rasayan Journal of Chemistry. Jul-Sep2024, Vol. 17 Issue 3, p1222-1229. 8p.
Autor:
J. C. BARRISH, E. GORDON, M. ALAM, P.-F. LIN, G. S. BISACCHI, P. CHEN, P. T. W. CHENG, A. W. FRITZ, J. A. GREYTOK, M. A. HERMSMEIER, W. G. HUMPHREYS, K. A. LIS, M. A. MARELLA, Z. MERCHANT, T. MITT, R. A. MORRISON, M. T. OBERMEIER, J. PLUSCEC, M. SKOOG, W. A. SLUSARCHYK, S. H. SPERGEL, ET AL. ET AL.
Publikováno v:
ChemInform. 25
Autor:
G. S. Bisacchi, Jack Z. Gougoutas, Robert Zahler, Janak Singh, Mary F. Malley, Richard H. Mueller, J. D. Jun. Godfrey, T. P. Kissick, J. D. Di Marco, T. Mitt
Publikováno v:
ChemInform. 26
Autor:
P. CHEN, P. T. W. CHENG, M. ALAM, B. D. BEYER, G. S. BISACCHI, T. DEJNEKA, A. J. EVANS, J. A. GREYTOK, M. A. HERMSMEIER, W. G. HUMPHREYS, G. A. JACOBS, O. KOCY, P.-F. LIN, K. A. LIS, M. A. MARELLA, D. E. RYONO, A. K. SHEAFFER, S. H. SPERGEL, C. SUN, J. A. TINO, G. VITE, R. J. COLONNO, ET AL. ET AL.
Publikováno v:
ChemInform. 27
Autor:
Robert Zahler, Alain Martel, Richard J. Colonno, G. S. Bisacchi, O. Kocy, S. Innaimo, M. G. Young, Jean-Paul Daris, G. A. Jacobs, Sam T. Chao, Z. Merchant, William A. Slusarchyk, Joseph E. Sundeen, Philippe Lapointe, C. Bachard
Publikováno v:
ChemInform. 28
Autor:
Z. Merchant, S. Skwish, Dorothy Slusarchyk, P.J. McCann, D.A. Young, M. Morella, Kenneth E.J. Dickinson, Michael Cap, Ravindar N. Girotra, Anita D. Russell, B.E. Abboa-Offei, William N. Washburn, G.T. Allen, A.V. Gavai, Belay Tesfamariam, Peter T. W. Cheng, G. S. Bisacchi, Tammy C. Wang, A A Seymour, T.W. Harper, C.M. Arbeeny, Tamara Dejneka, Amarendra B. Mikkilineni, Poss Kathleen M, Chongqing Sun, Philip M. Sher, T.L. Waldron, R.J. George, B.H. Frohlich, Ginger Wu, Denis E. Ryono
Publikováno v:
Bioorganicmedicinal chemistry letters. 14(13)
A series of N-(4-hydroxy-3-methylsulfonanilidoethanol)arylglycinamides were prepared and evaluated for their human β3 adrenergic receptor agonist activity. SAR studies led to the identification of BMS-201620 (39), a potent β3 full agonist (Ki=93 nM
Autor:
Peter T. W. Cheng, Jill A. Greytok, Ping Chen, Chongqing Sun, William G. Humphreys, M. Alam, K. A. Lis, G. A. Jacobs, S. H. Spergel, A. J. Evans, M. A. Marella, P.-F. Lin, Amy K. Sheaffer, Mark A. Hermsmeier, Tamara Dejneka, G. S. Bisacchi, Gregory D. Vite, Robert Zahler, Richard J. Colonno, B. D. Beyer, Denis E. Ryono, Joel C. Barrish, O. Kocy, Joseph A. Tino
Publikováno v:
Journal of medicinal chemistry. 39(10)
A series of novel aminodiol inhibitors of HIV protease based on the lead compound 1 with structural modifications at P1' were synthesized in order to reduce the cytotoxicity of 1. We have observed a high degree of correlation between the lipophilicit
Autor:
G, Yamanaka, A V, Tuomari, M, Hagen, B, McGeever-Rubin, B, Terry, M, Haffey, G S, Bisacchi, A K, Field
Publikováno v:
Molecular pharmacology. 40(3)
The cycloburtane nucleoside analog (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine [(R)-BHCG or SQ 34,514] was recently synthesized and shown to be the active enantiomer of (+/-)-BHCG (SQ 33,054), a potent inhibitor of several